StockNews.AISignal intelligence

Public signal · 1-minute delayed

Signal brief

Source-backed market context you can read and share without an account.

Browse signals
PGNYBearishEarningsnews
High materiality8/10

These Analysts Slash Their Forecasts On Progyny Following Q3 Results

Nov 13, 2024, 10:09 AM EST1 sourcesAI-analyzed
Why it may matterVerify against the original reporting

Missed earnings and low guidance typically lead to stock price declines, similar to past results affecting shares.

AI summary

What happened, with direct paths to the underlying reporting

Progyny's Q3 earnings missed analysts' estimates significantly. Company's revenue guidance for FY24 is below analyst expectations. Utilization rate patterns led to lower treatment consumption. Analysts downgraded Progyny's stock rating post-earnings announcement. Progyny shares fell 15.1%, reflecting investor disappointment.

  • Progyny's Q3 earnings missed analysts' estimates significantly.
  • Company's revenue guidance for FY24 is below analyst expectations.
  • Utilization rate patterns led to lower treatment consumption.
  • Analysts downgraded Progyny's stock rating post-earnings announcement.
  • Progyny shares fell 15.1%, reflecting investor disappointment.

How to read this signal

Transparent limits for an AI-generated research aid

StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.

Related signals

More source-backed signals connected by company or event

PGNYNov 18, 2025, 11:16 AM EST

Does Progyny Stock Lead The Pack?

Progyny leads fertility benefits with outcomes-based employer solutions. Stock up ~90% last year; market prices strong future growth. LTM revenue growth 11.4% and free cash flow m…

Read signal →